Literature DB >> 7590488

Small cell carcinoma of the ovary of the hypercalcemic type: p53 protein accumulation and clinicopathologic features.

J D Seidman1.   

Abstract

Twenty women with ovarian small cell carcinoma of the hypercalcemic type were studied. Mean patient age was 24 years, 11 had hypercalcemia, and the 2-year actuarial survival was 18%; there was only one long-term survivor. Twelve of 15 tumors tested (80%) exhibited p53 protein accumulation by immunohistochemistry, supporting the presence of p53 gene mutations in these tumors. p53 gene mutations may have an important role in the evolution of small cell ovarian carcinomas.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7590488     DOI: 10.1006/gyno.1995.0023

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  4 in total

1.  Recurrent SMARCA4 mutations in small cell carcinoma of the ovary.

Authors:  Petar Jelinic; Jennifer J Mueller; Narciso Olvera; Fanny Dao; Sasinya N Scott; Ronak Shah; JianJiong Gao; Nikolaus Schultz; Mithat Gonen; Robert A Soslow; Michael F Berger; Douglas A Levine
Journal:  Nat Genet       Date:  2014-03-23       Impact factor: 38.330

2.  A case of small cell carcinoma of the ovary hypercalcemic variant in a teenager.

Authors:  Arvind Bakhru; J Rebecca Liu; Amir Lagstein
Journal:  Gynecol Oncol Case Rep       Date:  2012-09-19

3.  Small cell ovarian cancer in adolescents: report of two cases and review of the literature.

Authors:  M Rovithi; A G Pallis; A Kalykaki; E Lagoudaki; L Giannikaki; E N Stathopoulos; K Relakis; V Georgoulias
Journal:  Case Rep Med       Date:  2011-05-31

Review 4.  Case Report of Small Cell Carcinoma of the Ovary, Hypercalcemic Type (Ovarian Rhabdoid Tumor) with SMARCB1 Mutation: A Literature Review of a Rare and Aggressive Condition.

Authors:  Maria Fernanda Evangelista Simões; Alexandre André Balieiro Anastácio da Costa; Tullio Novaes Silva; Lizieux Fernandes; Graziele Bovolim; Giovana Tardin Torrezan; Dirce Maria Carraro; Glauco Baiocchi; Ademir Narcizo Oliveira Menezes; Elizabeth Santana Dos Santos; Louise De Brot
Journal:  Curr Oncol       Date:  2022-01-18       Impact factor: 3.677

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.